Advanced search
Publication Cover
Journal of Drug Assessment Volume 11, 2022 - Issue 1
Journal homepage
2,086
Views
2
CrossRef citations to date
0
Altmetric
Transplants

A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen

Crystal Watsona Atara Biotherapeutics Inc., South San Francisco, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8763-9197
ORCID Icon,
Hemanth Gadikotab Maple Health Group LLC, New York, NY, USA
,
Arie Barleva Atara Biotherapeutics Inc., South San Francisco, CA, USA
&
Rachel Beckermanb Maple Health Group LLC, New York, NY, USA
Pages 1-11 | Received 27 Dec 2021, Accepted 29 Apr 2022, Published online: 03 Jun 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.